John Weiser, a doctor and researcher, has treated people with HIV since the beginning of the AIDS epidemic in the 1980s. He joined the CDC’s HIV prevention team in 2011 to help lead its Medical Monitoring Project, the only in-depth survey of HIV across the United States. The project has shaped the country’s response to…
Florida resident Keith Jones says his Affordable Care Act insurance plan was changed multiple times this year without his permission. Now the 52-year-old is struggling with his health problems while facing large premium bills he says he shouldn’t owe. The third time, he sought help from an insurance agent, who got Jones on the phone…
Mark Cuban warned that many employers are collecting drug rebate money funded by their sick employees — a practice that can violate fiduciary duties under ERISA. His company, Cost Plus Drugs, is partnering with organizations like Humana’s CenterWell to create direct-to-employer programs that bypass PBMs and deliver medications at lower net prices. The post Mark…
Through a partnership with Zocdoc, patients will be able to find providers who accept their insurance, view real-time availability for appointments and book appointments directly through the Healthgrades website. The post Zocdoc Partners with Healthgrades to Help People Book Doctor’s Appointments appeared first on MedCity News.
While insurance groups will continue covering hepatitis B vaccines without cost, the CDC’s new recommendation raises questions about the future of hepatitis B prevention efforts
Consultant David Pittman, M.P.H., outlines which aspects of CMS’ mandatory two-sided risk model will be most challenging for practices
Nancy Hunt arrived at an emergency room from a Genesis HealthCare nursing home in Pennsylvania in such dreadful shape, including maggots infesting her gangrened foot, that the hospital called an elder abuse hotline and then the police, her son alleged in a lawsuit. Hunt died five days later. Her death certificate said the foot injury…
YaoPharma’s once-daily oral GLP-1 drug is currently in Phase 1 testing. The license agreement gives Pfizer global rights to the small molecule, which it envisions as part of potential drug combinations. The post Pfizer’s Appetite for More Obesity Meds Leads to $150M Deal for Oral GLP-1 Drug From China appeared first on MedCity News.
To bend the cost curve, we need a smarter, more integrated approach to care management — one capable of addressing rising upstream cost drivers, while still delivering high-quality, patient-centered outcomes. The post Comorbidities Are Driving Up Healthcare Costs — Here’s How More Specialized Care Management Can Bring Them Under Control appeared first on MedCity News.
Healthcare’s next frontier isn’t policy reform or payment reform. It’s experience reform — reimagining every touchpoint between members, providers, and plans through the lens of design and empathy. The post If People Can Use TikTok, Why Can’t They Use Healthcare? appeared first on MedCity News.